Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.5 CHF | +0.42% | +1.39% | -3.16% |
Apr. 25 | Santhera Pharmaceuticals Swings to Profit in FY23; Revenue Grows | MT |
Apr. 25 | Santhera Pharmaceuticals Holding AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.16% | 95.38M | |
+4.16% | 70.78B | |
+10.72% | 9.15B | |
-17.03% | 4.84B | |
+37.51% | 4.22B | |
+3.92% | 3.92B | |
+18.14% | 2.55B | |
-24.13% | 2.26B | |
-29.70% | 2.24B | |
+9.09% | 1.92B |
- Stock Market
- Equities
- SANN Stock
- News Santhera Pharmaceuticals Holding AG
- Santhera Pharmaceuticals Seeks EU Marketing Approval For Duchenne Muscular Dystrophy Drug